Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Melanoma symptoms provide key warning signs that can help you find this disease early, when it is most treatable. Learn ...

Medically reviewed by Marla Anderson, MD Diagnosing melanoma typically requires a physical exam and a biopsy. Imaging and ...